Latham & Watkins LLP represented Reddit in the offering. Reddit, Inc., a community of communities, has announced the pricing of its initial public offering of an...
Reddit’s US$748 Million Initial Public Offering
Boston Scientific’s $850 Million Acquisition of Relievant MedSystems
Faegre Drinker advised Boston Scientific, and Latham & Watkins advised Relievant MedSystems on the deal. Boston Scientific Corporation (NYSE: BSX) announced it has entered into a...
Otsuka’s Collaboration with ShapeTX
Latham & Watkins advised ShapeTX on the deal. Otsuka Pharmaceutical Co., Ltd. and ShapeTX announced a multi-target collaboration to develop intravitreally-delivered adeno-associated viruses (AAVs) for ocular...
Neumora Therapeutics’ $250.1 Million Initial Public Offering
Latham & Watkins advised Neumora, and Cooley advised the underwriters. Neumora Therapeutics, Inc. announced the pricing of its initial public offering of 14,710,000 shares of its common...
Endava’s Acquisition of TLM
Latham & Watkins Advises TLM in Acquisition by Endava. Endava, a global provider of digital transformation, agile development and intelligent automation services, acquired TLM Partners, Inc...
NextRoll’s $50 Million Financing Deal From Capital IP
Latham & Watkins advises NextRoll in US$50 million financing deal from Capital IP. NextRoll, the San Francisco-based marketing technology company delivering products for ambitious marketers to...
Guardant Health’s Upsized Public Offering of Common Stock
Latham & Watkins Advises Guardant Health in Pricing of Upsized Public Offering of Common Stock. Guardant Health, Inc., a leading precision oncology company, has announced the pricing...
Vaxcyte’s $500 Million Public Offering
Cooley advises Vaxcyte on the offering, and Latham & Watkins advises the underwriters. Vaxcyte, Inc. (Nasdaq: PCVX) has announced the pricing of an underwritten public offering...
Sanofi, AstraZeneca and Sobi’s Streamlining of Nirsevimab Contractual Arrangements
Latham & Watkins represented Sobi in the transaction. Sanofi has simplified its contractual arrangements relating to the development and commercialization of Beyfortus (nirsevimab) in the United...
Sonoma Biotherapeutics’ Collaboration Agreement with Regeneron Pharmaceuticals
Latham & Watkins advised Sonoma Biotherapeutics on the transaction. Sonoma Biotherapeutics, Inc. and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a collaboration to apply their scientific and...
dbt Labs’ Acquisition of Transform Data
Latham & Watkins advised dbt Labs on the deal. dbt Labs announced that it has signed a definitive agreement to acquire Transform Data Inc. The acquisition...
Discord’s Acquisition of Gas App
Latham & Watkins LLP represented Discord in the transaction, while Wilson Sonsini advised Gas. Discord, a voice, video, and text communication service used by over one hundred...